| Descriptor English: | Febuxostat | ||||
| Descriptor Spanish: |
Febuxostat
| ||||
| Descriptor Portuguese: | Febuxostat | ||||
| Descriptor French: | Fébuxostat | ||||
| Entry term(s): |
2-(3-cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylic acid 6720, TEI TEI 6720 TEI-6720 TEI6720 Uloric |
||||
| Tree number(s): |
D02.886.675.274 D03.383.129.708.274 |
||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000069465 | ||||
| Scope note: | A thiazole derivative and inhibitor of XANTHINE OXIDASE that is used for the treatment of HYPERURICEMIA in patients with chronic GOUT. |
||||
| Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||
| Pharm Action: |
Gout Suppressants |
||||
| Registry Number: | 101V0R1N2E | ||||
| CAS Type 1 Name: | 5-Thiazolecarboxylic acid, 2-(3-cyano-4-(2-methylpropoxy)phenyl)-4-methyl- | ||||
| Public MeSH Note: | 2016; FEBUXOSTAT was indexed under THIAZOLES 1994-2015 |
||||
| History Note: | 2016 (1994) |
||||
| DeCS ID: | 55905 | ||||
| Unique ID: | D000069465 | ||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
| Date Established: | 2016/01/01 | ||||
| Date of Entry: | 2015/07/01 | ||||
| Revision Date: | 2016/05/31 |
-
-
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
|
Febuxostat
- Preferred
TEI 6720
- Narrower
Uloric
- Narrower
2-(3-cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylic acid
- Narrower
| Concept UI |
M0224789 |
| Scope note | A thiazole derivative and inhibitor of XANTHINE OXIDASE that is used for the treatment of HYPERURICEMIA in patients with chronic GOUT. |
| Preferred term | Febuxostat |
| Concept UI |
M0473600 |
| Preferred term | TEI 6720 |
| Entry term(s) |
6720, TEI TEI-6720 TEI6720 |
| Concept UI |
M0544237 |
| Preferred term | Uloric |
| Concept UI |
M0224787 |
| Preferred term | 2-(3-cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylic acid |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey